Table 2.
Clinical characteristics of kidney or liver transplant recipients with TB compared with controls
| Characteristics | Cases (n = 45) | Controls (n = 45) | P |
|---|---|---|---|
| Univariate analysis |
|
|
|
| Age, mean years ± SD |
37.9 ± 10.0 |
37.8 ± 10.0 |
0.974 |
| Gender, number of male/number of female |
34/11 |
34/11 |
- |
| Donor type, Deceased/the others |
32/13 |
22/23 |
0.031 |
| The type of transplantation, Liver/Kidney |
2/43 |
2/43 |
- |
| Two or more transplants |
4 |
4 |
1.000 |
| Tacrolimus/Cyclosporine |
34/10 |
34/11 |
0.849 |
| Use of antilymphocytic agents |
7 |
14 |
0.081 |
| Preoperative evidence of latent TB1 |
17 |
5 |
0.003 |
| Diabetes mellitus |
7 |
7 |
1.000 |
| Rejection, n (%) |
15 |
13 |
0.649 |
| CMV infection |
18 |
5 |
0.012 |
| HCV, HBV |
10 |
10 |
1.000 |
| Major infection2 |
13 |
16 |
0.499 |
| Multivariate analysis |
OR |
(95% CI) |
|
| Graft from a cadaveric donor |
3.7 |
(1.4-10.0) |
0.010 |
| Preoperative evidence of latent TB | 6.8 | (2.0 - 22.7) | 0.002 |
1Including positive PPD or IGRA, untreated TB lesion on plain chest radiograph, recent TB contact history.
2Including pneumonia,bloodstream infections,urinary tract infection or intracranial infection.
TB, tuberculosis; SD, standard deviation; DCD, donation after cardiac death; CMV, cytomegalovirus; HCV, Hepatitis C Virus; HBV, Hepatitis B Virus; ESR, Erythrocyte Sedimentation Rate; OR, odds ratio; CI, confidence interval.